Overview
Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients
Status:
Unknown status
Unknown status
Trial end date:
2011-09-01
2011-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the pharmacokinetics of rectal and sublingual administration of tacrolimus and to compare with pharmacokinetics after oral administration of tacrolimus in renal transplant patients before transplantation.Phase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Maastricht University Medical CenterTreatments:
Tacrolimus
Criteria
Inclusion Criteria:- Patients that will have a kidney transplant patient and will be treated with
tacrolimus. As well as hemodialysis patients as well as peritoneal dialysis patients
are included.
- Age: 18 - 65 years
- Patient's informed consent
Exclusion Criteria:
- Patients that use drugs that interact with tacrolimus
- Patients that participate in other studies
- Patients that are treated with tacrolimus